Children treated with dietary restriction for food intolerance may require calcium supplementation, particularly if cows' milk and milk substitutes are not tolerated'P, We report two children with atopic eczema who reacted adversely to a number of calcium supplement formulations.
Summary
Children treated with dietary restriction for food intolerance may require calcium supplementation, particularly if cows' milk and milk substitutes are not tolerated'P, We report two children with atopic eczema who reacted adversely to a number of calcium supplement formulations.
Case reports Case 1
This boy developed atopic eczema at the age of six months. He failed to respond to conventional topical therapy with emollients and corticosteroids". There was a history of angioedema following the ingestion of egg, fish and yellow split peas, and worsening of eczema following the ingestion of fish, egg, cow's milk, wheat, tomato, strawberry and blackcurrant. There was also a history of contact urticaria from grass and exacerbation of eczema following exposure to house dust and animals. By the age of 2 years 9 months 40% of his skin surface area was affected by eczema. His serum IgE concentration was 68 000 iuJml (normal for age < 42 iu/ml), RAST tests against a panel of 17 foods gave a grade 4 positive result for egg, and grade 3 positives for potato, pork, hazelnut, peanut, rice, corn, wheat and cod. Of the remaining eight foods, seven were positive at grade 2. RAST tests against inhalants were all positive: house dust mite (4), dog (3), timothy grass (3), cat (2) . A human serumalbumin control disc was also positive at grade 2, implying that some ofthe positive responsiveness was a non-specific binding effect of the very high total serum IgE level.
He was put on a diet which eliminated all foods except for lamb, potato, rice, rice crispies, and Brussels sprouts', with marked improvement in his eczema. Food challenges were then commenced, single foods being reintroduced at the rate of one per week. Intolerance to cow's milk, soya milk and casein hydrolysate milk formula necessitated calcium supplementation because of a low dietary calcium intake. Calcium-with-vitamin D tablets" (calcium sodium lactate 450 mg, calcium phosphate 160 mg and calciferol 12.5 /Lg, containing a total of 1.975 mmol elemental calcium per tablet) were prescribed, one to be taken daily. Within 2 days his eczema worsened, and it continued to do so for the next 6 weeks. The tablets were then discontinued, with rapid improvement in the eczema.
At the age of 3 years 7 months he was started on effervescent calcium gluconate tablets! (calcium gluconate 1000 mg, saccharin sodium 1 mg, anhydrous citric acid 150 mg, tartaric acid 300 mg, sodium bicarbonate 375 mg, containing 2.25 mmol elemental calcium per tablet) one tablet per day. Within 2 days of starting treatment he developed a florid itchy erythematous rash which resolved when the tablets were discontinued. An identical reaction was provoked by a further trial of the same tablets 3 months later.
By the age of 4 years 8 months, he was tolerating only 15 foods, but not cow's milk, soya or casein hydrolysate. His calcium intake was estimated by a 5-day dietary survey" to be only 80 mglday (recommended daily allowance 600 mg") and a further attempt to administer calcium was made by giving calcium gluconate powder, 2.8 g (containing 6.3 mmol of elemental calcium) daily. His eczema markedly worsened within 2 days. His parents were persuaded to continue to give the powder for a further 2 weeks, but his eczema became both more extensive (affecting 80% of his skin surface area) and more severely inflamed. This exacerbation resolved within a week of cessation of calcium administration.
At the age of 4 years 10 months, he was admitted to hospital. A 10% solution of calcium gluconate was diluted in a dextrose 4%/sodium chloride 0.18% solution to provide 6.75 mmol calcium per 24 h, and given intravenously. Within three days, there was a marked increase in itching, and the infusion was discontinued. After 4 days there was a generalized itchy erythematous rash accompanied by marked worsening of the eczema. His condition had returned to the pre-infusion state within 7 days of discontinuation. Vitamin A and D supplementation was commenced in the form of vitamin A and D capsules (containing vitamin A 4000 units and vitamin D 400 units), one capsule daily.
At the age of 5 years 4 months he still had eczema affecting 30% of his skin surface area, he remained intolerant to a wide range of foods, and a 5-day diet survey showed a calcium intake of 182 mg per day (recommended daily allowance 600 mg"), Accordingly, he was commenced on calcium carbonate 2 g (containing 20 mmol elemental calcium) powder, three times a day. A marked increase in itching was noted within 24 h of the first dose, by 48 h the itching was severe, and on the 3rd day he developed generalized urticaria. The calcium was discontinued on the 3rd day, and a week later his condition had returned to its usual state. A further attempt to administer calcium carbonate had the same effect. At the age of 6 years, his serum calcium concentration was 2.37 mmolll (normal 2.25-2.65), phosphate 1.56 mmolll (normal 1.0-1.8), alkaline phosphatase 122 iull (normal 90-300) and albumin 35 gil (normal 30-46).
Case 2
This breast-fed girl developed atopic eczema at the age of 3 months, shortly after solid foods were introduced into her diet. By the age of 5 years she had severe eczema affecting 70% of her skin surface, which was unresponsive to conventional topical therapy with corticosteroids and emollients. There was a history of urticaria, angioedema, vomiting and loose stools following the ingestion of egg and wheat, and a suspicion that ingestion of a number of other foods caused worsening of her eczema. Her serum IgE concentration was 38 000 iuJml (normal for age <42 iu/ml). RAST tests against a panel of 17 foods gave a positive result in 16 (grade 4 in 5; grade 3 in 4; grade 2 in 6; grade 1 in 1), with a negative result for carrot and the human serumalbumin control. RAST tests against inhalants were all positive: house dust mite (grade 4), timothy grass (3), dog (3), cat (2) . She was treated in hospital with an elemental diet", and discharged much improved on a diet of lamb, rice and brussels sprouts. Following discharge, foods were reintroduced singly into her diet, at the rate of one per week.
Because of intolerance to a large number of foods(including cow's milk, soya milk and casein hydrolysate milk formula), she was only taking 15 foods by the age of 7 years. A 5-day dietary survey" showed a daily calcium intake of 195 mg (recommended daily allowance 600 mg"), and she was therefore prescribed calcium-with-vitamin D tablets, 0141·07681901 080497-021$02.00/0 ©1990 The Royal Society of Medicine one daily. Two days after starting these tablets, she suffered intense itching. Her eczema rapidly worsened, but improved after withdrawal of the tablets. Further trials ofthe tablets produced the same result.
At the age of 7 years 10 months, effervescent calcium gluconate tablets were prescribed, but within one hour of taking the first tablet she developed marked itching, and this was followedby worsening of her eczema. Three further attempts to give effervescent calcium gluconate produced itching within one hour of ingestion, followed by exacerbation of eczema. She was commenced on astemizole (a long acting HI antihistamine) 5 mg daily and ranitidine (an H2 antihistamine) 75 mg twice daily, and then given calciumwith-vitamin D tablets one per day, again with the same adverse reaction as before.
At the age of 8 years 6 months, she was tolerating 30 foods but this did not include any milk or milk substitute. Ten millilitres of 10% calcium gluconate in dextrose 4%/saline 0.18% was infused over 5 hours, with no immediate reaction. However, two hours after finishing the infusion, she developed severe itching with generalized erythema, which settled after 48 hours. She has subsequently tolerated a soyabased milk formula, obviating the need for calcium supplementation.
Discussion
We have been unable to find previous reports of intolerance to calcium supplements. The adverse reactions began within 48 h of oral administration and after 24 h of intravenous administration in case 1. The timing of the reactions in case 2 was less consistent, occurring 1-24 h after oral administration and 7 hours after intravenous administration. Despite the repeated history of intolerance in each case, doubleblind placebo-controlled confirmation with intravenous challenges is lacking and was not sought, as it would have entailed prolonged admission to hospital.
The possible mechanism is obscure. Lactose is an excipient in a number of tablets, including calciumwith-vitamin D tablets. Oral medications usually contain excipients derived from plant or animal sources, and it is possible that residual traces of protein could trigger an immunologically-mediated reaction. For example, effervescent calcium gluconate tablets contain stearic acid and stearates derived from animal or vegetable fat, and calcium-and-vitamin D tablets contain corn starch, lactose from cow's milk and vitamin D from animal sources. In one study, reagent grade lactose was found to contain (j·lactoglobulin and a-lactalbumin as well as four other unidentified antlgens", and it is known that pharmaceutical grade lactose does contain traces of protein (personal communication from Lactochem, Crewe, Cheshire). These protein impurities are often 'built-in' to the crystal lattice structure during crystallization, and indeed may form the nidus for the initial crystallization itself (personal communication from Laetochem).Thus it is theoretically possible that lactose, either added to a cow's milk substitute or used as an excipient in a tablet or capsule, could cause intolerance in subjects with cow's milk protein intolerance, although this hasnever been documented. Urticarial reactions to certain colouring agents and preservatives contained in some medicines are well described 9 ,1O, but none of the preparations given to our patients contained such additives. Saccharin, which is present in effervescent calcium gluconate tablets, has been reported to cause urticarla-'. Vanillin, the flavouring in calcium-and-vitamin D tablets, is a well recognized sensitizer in contact dermatltisl''.
It is possible that the calcium ion is directly responsible for the adverse reaction. Extracellular calcium is generally necessary for mast cell degranulation'", However, increasing concentrations of calcium do not increase degranulation, and very high concentrations in vitro may even be inhibitory's. No effect would be expected in the narrow physiological range of serum ionised calcium. It is of interest that calcium gluconate as tablets or given by intramuscular injection used to be given as treatment for urticaria, although there was no clear rationale for this approach'", In addition, calcium-and-vitamin D tablets have been recommended for the treatment of angioedema due to bee atings'". In any case, it is difficult to postulate a dose-related pharmacological effect of oral calcium supplements, as the estimated daily intake of our patients still fell well below the recommended daily allowance (600 mg)? while they were taking supplements (case 1: 165 mg/day, case 2: 275 mg/day).
